Fatty acid [g/day] | Treatment1 | SEM | P-value | ||
---|---|---|---|---|---|
 | CON | CLA |  | Trt | Trt x WL2 |
4:0 | 37.3 | 33.5 | 1.9 | 0.186 | 0.470 |
6:0 | 29.8 | 23.3* | 1.6 | 0.016 | 0.767 |
8:0 | 16.6 | 11.8* | 1.2 | 0.011 | 0.824 |
10:0 | 41.1 | 27.5* | 3.2 | 0.015 | 0.888 |
12:0 | 47.1 | 30.4* | 3.8 | 0.013 | 0.931 |
14:0 | 129 | 104 | 8.1 | 0.059 | 0.858 |
c 9-14:1 | 11.0 | 6x.9 | 1.3 | 0.052 | 0.977 |
15:0 | 14.8 | 10.2 | 1.5 | 0.055 | 0.430 |
16:0 | 364 | 267* | 19.7 | 0.009 | 0.346 |
c 9-16:1 | 15.2 | 12.8 | 1.3 | 0.240 | 0.800 |
17:0 | 5.8 | 5.0 | 0.4 | 0.182 | 0.410 |
18:0 | 72.3 | 72.9 | 4.5 | 0.927 | 0.261 |
t 6/t 7/t 8-18:1 | 1.2 | 1.6 | 0.15 | 0.075 | 0.250 |
t 9-18:1 | 1.7 | 2.1 | 0.14 | 0.078 | 0.484 |
t 10-18:1 | 2.6 | 4.3 | 0.62 | 0.080 | 0.708 |
t 11-18:1 | 5.0 | 6.1 | 0.38 | 0.073 | 0.364 |
t 12-18:1 | 2.1 | 2.6 | 0.20 | 0.121 | 0.220 |
t 13/t 14-18:1 | 2.5 | 2.7 | 0.21 | 0.590 | 0.033 |
c 9-18:1 | 139 | 150 | 8.5 | 0.375 | 0.388 |
c 11-18:1 | 6.0 | 6.4 | 0.67 | 0.671 | 0.624 |
c 12-18:1 | 1.9 | 2.4 | 0.19 | 0.075 | 0.253 |
c 13-18:1 | 0.7 | 0.8 | 0.06 | 0.664 | 0.911 |
18:2 n-6 | 13.3 | 14.5 | 0.97 | 0.384 | 0.924 |
18:3 n-3 | 0.31 | 0.24 | 0.02 | 0.069 | 0.253 |
CLA | |||||
 c 9,t 11-CLA | 3.4 | 4.3 | 0.34 | 0.093 | 0.767 |
 t 10,c 12-CLA | 0.00 | 0.37* | 0.04 | 0.000 | 0.030 |
 Other CLA | 0.73 | 0.91 | 0.07 | 0.078 | 0.211 |
Summations | |||||
  ∑ SFA | 781 | 608* | 39.9 | 0.014 | 0.582 |
  ∑ MUFA | 199 | 208 | 11.5 | 0.626 | 0.444 |
  ∑ PUFA | 24.5 | 26.8 | 1.7 | 0.374 | 0.762 |
  ∑ trans-18:1 | 19.7 | 24.7 | 1.9 | 0.103 | 0.254 |
  ∑ BCFA3 | 17.1 | 16.0 | 0.81 | 0.347 | 0.346 |
  ∑ C164 | 380 | 280* | 20.9 | 0.010 | 0.366 |
  ∑ de novo5 | 345 | 261* | 21.4 | 0.021 | 0.947 |
  ∑ preformed6 | 282 | 301 | 13.9 | 0.358 | 0.291 |
Ratio | |||||
  c 9-14:1/14:0 | 0.86 | 0.55 | 0.10 | 0.060 | 1.000 |